<DOC>
	<DOCNO>NCT00954863</DOCNO>
	<brief_summary>Based investigator previous study , seventy-four 786 HIV-1 isolates ( 9.4 % ) , collect 1999 2006 , harbor one primary mutation associate antiretroviral resistance reverse-transcriptase inhibitor ( RTIs ) protease inhibitor ( PIs ) naïve patient . However , drug resistance profile HIV-1 integrase gene unclear . Three objective propose : 1 . To investigate compare drug resistance profile HIV-1 integrase gene experience naive patient , expose Raltegravir . 2 . To investigate compare drug resistance profile HIV-1 integrase gene different subtypes ( subtype B , CRF01_AE CRF07_BC ) . 3 . To identify potential amino acid mutation integrase gene , might affect efficacy Raltegravir .</brief_summary>
	<brief_title>Genotypic Resistant HIV Strains Taiwan</brief_title>
	<detailed_description>From 2008 2009 , blood sample collect consecutive HIV-1-infected patient receive HIV care National Taiwan University Hospital . We expect collect 100 case antiretroviral naïve 100 case treatment-experienced patient . A standardized case collection form use record data demographic clinical characteristic laboratory result , plasma HIV RNA load ( PVL ) CD4 cell count . PVL quantify Cobas Amplicor HIV-1 MonitorTM Test , version 1.5 , ( Roche Diagnostics Corporation , Indianapolis , USA ) accord manufacturer 's protocol . The CD4 cell count determine use FACSFlow ( Becton Dickinson ) . This study approve Institutional Review Board hospital . The in-house genotypic drug resistance test perform determine drug resistance profile HIV-1 pol gene , focus protease , reverse transcriptase , integrase . Drug resistance mutation identify use HIVdb program Stanford University HIV Drug Resistance Database ( http : //hivdb.stanford.edu ) , accordance drug-resistance mutation list International AIDS Society-USA Consensus Guidelines [ 24 ] . Strains genetic mixture wild-type mutant sequence amino acid residue code major drug resistance consider drug resistant . Based interpretation give HIVdb program , sequence divide drug-resistant sequence , interpret high , intermediate , low level resistance , sensitive sequence , interpret sensitive potentially resistant . Multi-drug resistance ( MDR ) define genotypic resistance one class antiretroviral drug . Reference sequence various subtypes recombinant retrieve Los Alamos database ( http : //hiv-web.lanl.gov/seq-db.html ) . Sequences align Clustal W list MEGA ( molecular evolutionary genetics analysis ) analytical package ( version 3.0 ) [ 25 ] minor manual adjustment . The phylogenetic tree construct neighbor-joining method base Kimura 2-parameter distance matrix list MEGA software . Bootstrap value great 750 1,000 replicates consider significant . The phenotype specific unique amino acid mutation integrase gene determine use in-house phenotypic assay . Briefly , p7 vif fragment , 3.6kb , amplify patient ' plasma viral RNA clone backbone viral clone ( Figure 1 ) . The resultant clone transfected 293 cell produce infectious virus , whose titer determine p24 assay equal amount viruses subsequently use infect PBMC healthy donor . Virus titer supernatant infect cell 3 , 5 , 7 day post infection presence absence test compound determine real-time PCR p24 assay . The minimal concentration compound require reduce 50 % supernatant viral copy ( EC50 ) calculate regression analysis dose-response curve generate real-time PCR p24 assay .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIVinfected individual</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>